This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by David Smith in Drug Delivery Systems
Introduction
David Smith is an accomplished inventor based in Omaha, NE (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that focuses on light illumination-induced drug release. His work is pivotal in advancing medical treatments and enhancing the efficacy of drug delivery mechanisms.
Latest Patents
David Smith holds a patent for "Liposomal compositions with light illumination-induced drug release." This invention provides a small molecule delivery system that utilizes illumination to induce the release of small molecules. The system is based on a binary combination of charged liposomes containing small molecules and oppositely charged conjugates of a peptide with a photosensitizer attached to one end of the peptide chain. This innovative approach allows for binding to liposomes and their permeabilization upon light illumination, offering a novel method for targeted drug delivery.
Career Highlights
David Smith is affiliated with Creighton University, where he continues to engage in research and development in the field of drug delivery systems. His work has garnered attention for its potential applications in various medical treatments, showcasing his commitment to advancing healthcare through innovation.
Collaborations
David collaborates with notable colleagues, including Igor Meerovich and Michael Nichols. Their combined expertise contributes to the ongoing research and development efforts at Creighton University, fostering an environment of innovation and discovery.
Conclusion
David Smith's contributions to drug delivery systems exemplify the impact of innovative thinking in the medical field. His patent on light illumination-induced drug release represents a significant advancement in targeted therapies, highlighting the importance of continued research and collaboration in driving medical innovations forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
